Aprotinin: Effective, but risky?
James D. Perkins – 25 July 2006
Induction immunosuppression with rabbit antithymocyte globulin in pediatric liver transplantation
Ashesh Shah, Avinash Agarwal, Richard Mangus, Joel Lim, Jonathan Fridell, Rodrigo Vianna, A. Joseph Tector – 25 July 2006 – Routine use of rabbit antithymocyte globulin (RATG) induction therapy remains controversial in pediatric liver transplantation. We reviewed our experience of 18 cadaveric liver transplants in 18 children over a span of 2 years. All patients received the same immunosuppression: perioperative steroid therapy with taper, 3 doses of RATG, and maintenance therapy of steroids and tacrolimus started on postoperative day 3. Mean follow‐up was 2.2 ± 0.2 years.
Quality of life and liver transplantation in patients with polycystic liver disease
Amy A. Dan, Zobair M. Younossi – 25 July 2006
Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier
Bernhard Zöllner, Heinz‐Hubert Feucht, Martina Sterneck, Hansjörg Schäfer, Xavier Rogiers, Lutz Fischer – 25 July 2006 – Hepatitis B virus (HBV) DNA is detectable in a number of liver transplant candidates who are negative for hepatitis B surface antigen (HBsAg). After liver transplantation (LT), such patients may have molecular and/or serologic evidence of HBV replication. However, clinical disease from reactivation of occult HBV infection after LT has not been described.
Understanding the splenic contribution to portal flow: The role of splenic artery ligation as inflow modification in living donor liver transplantation
Dympna M. Kelly, Charles Miller – 25 July 2006
Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: Use of polymerase chain reaction
Maha A. Assi, Matthew J. Binnicker, Nancy L. Wengenack, Paul J. Deziel, Andrew D. Badley – 25 July 2006 – Coccidioidomycosis has been previously described in recipients of solid organ transplantation, especially in patients who have lived in or have visited areas endemic for Coccidioides spp. We present a case of coccidioidomycosis in a liver transplant recipient with several unique aspects, including negative serology and positive polymerase chain reaction results. Liver Transpl 12:1290–1292, 2006. © 2006 AASLD.
Comment on “Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantation”
Evan G. Pivalizza, Steven I. Abramson, Nicholas C. Lam, Robert D. Warters – 25 July 2006
Reply: Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations
Luc Massicotte, Serge Lénis, Lynda Thibeault, André Roy – 25 July 2006
Reply: Reduction of blood product transfusion requirements during liver transplantation
Luc Massicotte, Serge Lénis, Lynda Thibeault, Marie‐Pascale Sassine, Robert F. Seal, Andre Roy – 25 July 2006
Vascular reconstruction and complications in living donor liver transplantation in infants weighing less than 6 kilograms: The Kyoto experience
Yasumasa Shirouzu, Mureo Kasahara, Daisuke Morioka, Seisuke Sakamoto, Kaoru Taira, Kenji Uryuhara, Kohei Ogawa, Yasutsugu Takada, Hiroto Egawa, Koichi Tanaka – 25 July 2006 – Smaller‐size infants undergoing living‐donor liver transplantation (LDLT) are at increased risks of vascular complications because of their smaller vascular structures in addition to vascular pedicles of insufficient length for reconstruction. Out of 585 child patients transplanted between June 1990 and March 2005, 64 (10%) weighing less than 6 kg underwent 65 LDLTs.